Skip to main content
Caplight Logo









Nanose Medical

Nanose Medical

Private
NetanyaHealthcare & Life Scienceshttps://nanosemed.com/

Last Round

Grant

Jan 1, 2024

Total Funding Raised

$9.13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nanose Medical is a diagnostic equipment company that develops a portable, non-invasive sensing device designed to detect volatile biomarkers in breath for early screening of lung cancer and metabolic dysfunction-associated steatohepatitis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Sensors, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

breath analysiselectronic nosenon-invasive diagnosticse-nosebreath biopsyvolatile organic compoundsVOC analysismedical AIearly disease detectionbreathalyzer diagnosticspoint-of-care testingPOC testinglung cancer screeningliver disease diagnosisnanosensorbiomarker detectiondiagnostic equipmentMASH diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanose Medical Comparables

Compare Nanose Medical with similar companies based on industry and business-model similarity.

Nanose Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The eNose Company
87%
Noze
83%
Breathomix
82%

Nanose Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2024
GrantNov 1, 2023
GrantSep 1, 2023
GrantJan 1, 2023
SeedJun 1, 2021
Pre Seed
Nov 1, 2019

Key People

Founding team and executive leadership

Ilay Marom

Co-Founder & COO

Founding Team

Orit Marom Albeck

Co-founder And CEO

Founding Team

Omer Meroz

Chief Technology Officer, Head Of Sensors R&D

Executive Team

Nanose Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 3344% MoM, from 55 to 1.9K.

  • Jan 20, 2026

    Grew 50% QoQ, from 10 to 15 employees.

Nanose Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanose Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanose Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNetanya
Employee Range16
Year Founded2019
Last FundingJan 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?